Automated Robot to move and schedule readings of assay plates associated with an existing Mabtech reader
Closed Pre-Solicitation Posted
- Solicitation number
- SS-NIAID-25-2250859
- Agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- Not on record
- PSC
- Not on record
- Place of performance
- Hamilton, Montana 59840, United States
- Points of contact
Notice details come from SAM.gov. Updated .
About this opportunity
The National Institute of Allergy and Infectious Diseases (NIAID), a component of the Department of Health and Human Services, is seeking an Automated Robot to move and schedule readings of Mabtech-specific assay plates for clinical trial endpoint testing. The objective is to procure an Orbitor RS2 Automation Bundle with specific requirements, including a robot with a bi-directional telescoping arm, Momentum Scheduling Software, integration for up to 3 instruments, and 3 Random Access Plate Hotels. Vendors must submit a capability statement demonstrating an equivalent product manufactured in the United States, with all responses due by December 16, 2024, at 5:00 PM EST via the NIAID electronic Simplified Acquisition Submission System (eSASS). Respondents must be registered in SAM.gov and provide detailed organizational information and documentation supporting their capabilities. The agency emphasizes that this is a Sources Sought notice and does not obligate the government to award a contract.
This pre-solicitation notice has no specific set-aside designation and is open to all U.S. manufacturers meeting the technical specifications. The contract is specifically focused on equipment for T-cell Mabtech assays, requiring compatibility with an existing Mabtech IRIS reader and adherence to Buy American Act and Executive Order 14005 requirements. While no specific award value is mentioned, the procurement involves sophisticated laboratory automation equipment for clinical research purposes. Vendors must certify that their products are domestically manufactured and provide a comprehensive capability statement addressing the precise technical requirements. The solicitation follows standard federal procurement protocols, with the potential for a future formal solicitation to be published based on responses received to this sources sought notice.
Notice text
Sources Sought Announcement
Title: Automated Robot to move and schedule readings of Mabtech-specific assay plates associated with an existing Mabtech reader
ID: SS-NIAID-25-2250859
Post Date: December 10, 2024
Response Date: December 16, 2024
Classification Code: 6640
NAICS: 334516
This is a Sources Sought notice for domestically manufactured products only. This is NOT a solicitation for proposals, proposal abstracts, or quotations. Per the Buy American Act and Executive Order 14005, the National Institutes of Allergy & Infectious Disease (NIAID) is seeking information for domestically manufactured products only, Per the requirements under the Buy American Act and requirements relating to Executive Order 14005 entitled: “Ensuring the Future is Made in All of America by All of America’s Workers”, in the event that a nonavailability waiver request submitted through the Made in America Office (MIAO)’s Digital Waiver Portal is required." Respondents must certify in capabilities statement that products are manufactured in the United States.
The purpose of this notice is to obtain information regarding the availability and capability of all U.S manufactured products that are equal to the following product:
Automated Robot to move and schedule readings of Mabtech-specific assay plates associated with an existing Mabtech reader
Specifications:
The objective is to supply the automated solution equipment for the VIP to support clinical trial endpoint testing. This instrument must be equipped to be equivalent to an Orbitor RS2 Bundle with 3 Random Access Hotels. Required are an Orbitor RS2 Automation Bundle (RS2 Robot), Momentum Scheduling Software, Integration for up to 3 Instruments, and including 3 Random Access Plate Hotels, and Installation and Training.
Applications:
The equipment must perform T-cell Mabtech assays for functional readouts of clinical trial endpoints. The VIP requires the need to automate the transfer of assay plates and scheduling of assay plates on an existing Mabtech IRIS reader. The Orbitor RS2 Microplate robot has an innovative bi-directional telescoping arm that functions through a 360-degree workspace with barcode reader integration and assay plate de-lidding capability. The RS2 robot is compatible with Momentum Scheduling and integration software that Mabtech has communicated is the only previously used software for automated scheduling on their IRIS reader. These requirements, specifications and applications must be met for this requirement.
Capability Statement/Information Sought
All capable vendors should respond with a brief capability statement demonstrating an equal product that is manufactured in the United States by December 16, 2024, by 5:00 PM EST. Capabilities statement must also include the following information: 1) organization name, address, point of contact, email address, website address, telephone number, UE ID# with an active SAM.gov registration, and a tailored capability statements addressing the particulars of this effort, with appropriate documentation supporting claims of capability.
Submission Instructions
Interested businesses who consider themselves qualified to provide the above-listed items are invited to submit a response to this Sources Sought Notice by December 16, 2024 at 5:00 PM EST. All responses under this Sources Sought Notice must be submitted via the NIAID electronic Simplified Acquisition Submission System (eSASS) website at https://esass.nih.gov. All vendors must register in the eSASS system to submit their documentation. Instructions on how to register /submit documents are included on the website. All responses received by the closing date of this synopsis will be considered by the Government.
Disclaimer and Important Notes
This notice does not obligate the Government to award a contract or otherwise pay for the information provided in response. The Government reserves the right to use information provided by respondents for any purpose deemed necessary and legally appropriate. Any organization responding to this notice should ensure that its response is complete and sufficiently detailed to allow the Government to determine the organization’s qualifications to perform the work. Respondents are advised that the Government is under no obligation to acknowledge receipt of the information received or provide feedback to respondents with respect to any information submitted. After a review of the responses received, a pre- 3 solicitation synopsis and solicitation may be published in Federal Business Opportunities. However, responses to this notice will not be considered adequate responses to a solicitation.
Confidentiality
No proprietary, classified, confidential, or sensitive information should be included in your response. The Government reserves the right to use any non-proprietary technical information in any resultant solicitation(s).
Similar open opportunities
| Opportunity | Agency | Set-aside | Responses due |
|---|---|---|---|
| Combines Synopsis Solicitation- Automated Spatial | Office of Logisitics and Acquisition Operations | No set-aside | |
| Reagents and consumables for Roche immunostainers | Office of Logisitics and Acquisition Operations | No set-aside |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity